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Background/aim: In the general population, the frequency of thyroid micronodules is increasing, and the prevalence of malignancy
is higher for such nodules. Ultrasonography findings of these nodules are neither specific nor sensitive. The aim of this study was to
investigate the diagnostic value of elastography in patients with thyroid micronodules.
Materials and methods: A total of 224 patients with thyroid micronodules were recruited in this prospective study. All patients
underwent a thyroid fine-needle aspiration biopsy. Elastography scores (ESs) and strain indexes (SIs) were measured with real-time
ultrasound elastography.
Results: Malignant micronodules had higher ES and SI values than those of benign micronodules (P < 0.001). When ES was used to
diagnose malignancy, scores of >3 showed sensitivity of 79.4% and specificity of 98.1%. The area under the curve (AUC) for ES was
0.888 (P < 0.001). The optimal SI cutoff value that differentiated benign from malignant micronodules was 3.06 (98% sensitivity; 91%
specificity). The AUC for SI was 0.970 (P < 0.001).
Conclusions: ES and SI are beneficial markers for detecting malignant thyroid micronodules. We showed that SI is better than ES when
assessing the malignancy of thyroid micronodules.
Key words: Thyroid micronodules, malignancy, elastography, strain index

1. Introduction
Thyroid nodules are frequently discovered in clinical
practice, either during physical examination or incidentally
during imaging procedures. In the general population, up
to 50%–60% of healthy individuals have thyroid nodules
(1). The clinical significance of the evaluation of the
thyroid nodule is mainly related to the need for exclusion
of thyroid cancer, which accounts for 4%–6.5% of thyroid
nodule cases and is usually independent of the nodule
size (2,3). Fine-needle aspiration (FNA) is considered the
most accurate method for distinguishing benign thyroid
nodules from malignant ones (4). It is not appropriate to
evaluate all thyroid nodules with FNA because of the high
prevalence of such nodules.
Thyroid ultrasonography (US) is a valuable imaging
method widely used for the evaluation of thyroid nodules.
Although it is an inexpensive and noninvasive procedure,
it provides important information about the nodules,
such as the dimensions and parenchymal changes and
structure. Thyroid US features that have been found

to be independent risk factors for malignancy include
irregular margins, incomplete halo, hypoechogenicity,
microcalcifications, taller-than-wide shape, and central
vascularity (5). Nevertheless, the specificity, sensitivity,
positive predictive value (PPV), and negative predictive
value (NPV) of US is extremely variable across studies;
none of the abovementioned features have both high
specificity and high sensitivity (6,7).
Harder nodules generally tend to be malignant.
However, conventional US does not provide information
about the hardness of a nodule; therefore, elastography,
which is a noninvasive method to obtain information
about tissue stiffness, has been developed. Elastography
scores (ESs) and strain indexes (SIs) of malignant nodules
are higher than those of benign thyroid nodules (8,9).
It has been reported that elastography is useful for the
investigation of malignancy and may reduce the number
of unnecessary FNAs (10). ES and SI have been used to
differentiate benign and malignant thyroid nodules in
previous studies (11,12). However, their diagnostic value
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for thyroid micronodules has been assessed in only a
few reports (13,14). Therefore, we aimed to investigate
the diagnostic value of ES and SI for identifying the
characteristics of thyroid micronodules.
2. Materials and methods
This prospective study was conducted between January
2016 and March 2017 in our hospital at the Department
of Endocrinology and Metabolism outpatient clinic. The
patients who had nodules with diameter of ≤10 mm
determined on thyroid US at our hospital were enrolled
in the study. There were 26 males and 198 females aged
21–74 years. Thyroid fine-needle aspiration biopsy
(FNAB) were performed for all patients to investigate the
diagnostic values of ES and SI. They were operated on if
their cytology results confirmed or suspected malignancy
according to the Bethesda system (BS) (15). The study
protocol was approved by the ethics committee of our
hospital, and written informed consent was obtained from
all the participants.
Thyroid US and elastography were performed using
high-resolution B-mode gray-scale US, power Doppler
US, and real-time US elastography (Preirus HV with 13MHz linear transducer). Only one operator performed
all the measurements. The classical gray-scale features of
the nodules were evaluated. Color flow Doppler pattern
was classified as type 1 in the absence of blood flow, type
2 in the presence of perinodular blood flow, and type 3
in the presence of a marked intranodular blood flow (16).
ES measurements were classified using the Itoh elasticity
score scale (17).
Thyroid-stimulating hormone (TSH) and free T4
(fT4) levels were measured using a chemiluminescent
microparticle immunoassay (Abbott, Architect i2000,
Abbott Laboratories Diagnostics Division, USA). The
lower and upper limits were as follows: fT4: 0.58–1.60
ng/dL; TSH: 0.38–5.33 µIU/mL All the patients were
euthyroid, and serum calcitonin was undetectable.

2.1. Statistical analysis
Statistical analysis was performed using SPSS 17 (SPSS
Inc., Chicago, IL, USA). All the measurement data
were reported as the mean ± standard deviation, and
their differences were evaluated with the independent
sample t-test. Sensitivity, specificity, PPV, and NPV were
calculated from the cross tables. The associations between
the categorical variables and malignancy, ES, or SI were
evaluated using the Pearson chi-square test or Spearman
rank test. Receiver operating characteristic (ROC) curves
were analyzed, and the diagnostic performance of different
variables was expressed as the area under the curve (AUC).
P < 0.05 was considered statistically significant.
3. Results
The study included 198 (88.4%) females and 26 (11.6%)
males with solitary thyroid nodules sized ≤10 mm in
diameter on US. The mean age of the patients was 46.5
± 12.2 years. Each patient had only one nodule, and 117
(52.2%) nodules were on the right, 92 (41.1%) on the left,
and 15 (6.7%) in the isthmus. FNAB results of our study
showed that 44 (19.6%) nodules were malignant, 19 (8.5%)
were suspicious for malignancy, 43 (19.2%) had atypia
of undetermined significance (AUS), 108 (48.2%) were
benign, and 10 (4.5%) had nondiagnostic (ND) cytology.
ES was 1 in 17 cases and 2 in 63, all of which were
nonmalignant; 3 in 74 cases, four of which were suspected
of malignancy and nine of which were confirmed to
be malignant; 4 in 60 cases, 14 of which were suspected
of malignancy and 26 of which were confirmed to be
malignant; and 5 in 10 cases, one of which was suspected
of malignancy and nine of which were confirmed to be
malignant (Table 1). The patients whose FNAB results
confirmed or suspected malignancy underwent surgery.
According to the histopathological results, all of them
were diagnosed with papillary thyroid microcarcinoma.
Of the 63 nodules that were histopathologically
diagnosed as papillary microcarcinoma, 35 (55.6%)

Table 1. Distribution of the types of micronodules according to the elastosonography scores.
Score

Benign (%)

ND (%)

AUS (%)

Suspicious for malignancy (%)

Malignant (%)

1

16 (14.8)

0 (0.0)

1 (2.3)

0 (0.0)

0 (0.0)

2

47 (43.5)

5 (50.0)

11 (25.6)

0 (0.0)

0 (0.0)

3

43 (39.8)

3 (30.0)

15 (34.9)

4 (21.0)

9 (20.5)

4

2 (1.9)

2 (20.0)

16 (37.2)

14 (73.7)

26 (59.0)

5

0 (0.0)

0 (0.0)

0 (0.0)

1 (5.3)

9 (20.5)

Total

108 (100.0)

10 (100.0)

43 (100.0)

19 (100.0)

43 (100.0)

ND: Nondiagnostic. AUS: atypia of undetermined significance.
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were hypoechoic, 34 had (54%) microcalcification, 35
had (55.6%) irregular margin, and only one had halo
(1.6%). Doppler US showed that 10 of the 63 malignant
nodules (15.9%) had type 3 vascularization pattern;
there was no significant difference in the vascularity
pattern between benign and malignant micronodules (P
> 0.05). However, irregular margin, absence of peripheral
halo, hypoechogenicity, and microcalcification were
significantly different between the two groups (P < 0.001).
There were no significant differences in the TSH levels
between benign and malignant micronodules (1.8 ± 1.3
and 2.2 ± 1.2, respectively; P = 0.058)
There were significant differences between the mean ES
(2.3 ± 0.7 and 3.9 ± 0.6, respectively; P < 0.001) and SI (1.8
± 0.9 and 4.8 ± 1.5, respectively; P < 0.001) for benign and
malignant micronodules. We found that 52 micronodules
had ES of >3, of which 50 (96.1%) were malignant.
When we used ES to diagnose malignancy of thyroid
micronodules, the AUC of the ROC curve was 0.888 (95%
confidence interval: 0.826–0.950; P < 0.001; Table 2). ES
represented malignancy; sensitivity, specificity, PPV, and
NPV were 79.4%, 98.1%, 96.1%, and 89.1%, respectively
(Table 2).
The optimal SI cutoff value that could differentiate
between benign and malignant micronodules was 3.06,
with 98% sensitivity and 91% specificity (AUC: 0.970; 95%
confidence interval: 0.948–0.992; P < 0.001; Figure; Table 3).
4. Discussion
Thyroid nodules are commonly encountered in the general
population; in recent years, the frequency of occurrence
of thyroid nodules has increased (18). This increased
incidence is attributed to better diagnostic accuracy
and screening. Thyroid micronodules generally receive
clinical attention only after being incidentally detected
by the physician. The exclusion of thyroid cancer during
diagnosis is the main point in the investigation of these
micronodules. In recent years, thyroid cancer incidence
has substantially increased, particularly that of papillary
thyroid cancer (19), which can be attributed to papillary
microcarcinomas sized <1 cm (20).
Shrestha et al. grouped the nodules according to the
size of the maximum diameter as follows: group A, 0.5–0.9

cm; group B, 1.0–3.9 cm, and group C, ≥4 cm (21). The
subcentimeter nodules had the highest malignancy rate.
Cavallo et al. also investigated the association between
nodule size and malignancy and reported that malignancy
risk was inversely correlated with nodule size because
smaller nodules had higher malignancy rates (22).
In our study, we evaluated 224 micronodules with
FNAB, of which 108 were benign, 19 were suspected
of malignancy, and 44 were malignant. The patients
whose FNAB results confirmed or suspected malignancy
underwent surgery. According to histopathological results,
all these patients had papillary thyroid microcarcinoma.
When benign, suspected malignant, and malignant nodules
were evaluated based on FNAB (171 micronodules), the
prevalence of malignancy in micronodules was 36.8%,
which was higher than rates in other studies (21,22). Of
the 224 micronodules evaluated using FNAB, 43 (19.2%)
had AUS and 10 (4.5 %) had ND cytology. Moon et al., who
investigated 1440 nodules sized 0.2–1.0 cm in diameter
using FNAB, found that 17.8% were insufficient and
concluded that the nodule size was inversely proportional
to insufficiency rates (23).
In 2008, Mazzaferri and Sipos recommended that
FNAB should not be used for evaluating nodules of <0.5
cm in diameter because of the high rate of inadequate
specimens (24). On the other hand, the American
Association of Clinical Endocrinologists recommended
biopsy for nodules of ≤1 cm diameter and with suspicious
US features (10). However, the specificity, sensitivity,
PPV, and NPV for these criteria considerably differ across
studies. None of the US features have both high specificity
and high sensitivity (6,7).
Elastography might be an additional tool for the
diagnosis of thyroid carcinoma in micronodules in the
general population. In the present study, we investigated
the diagnostic performance of elastography for detecting
malignant thyroid micronodules. We showed that ES
and SI were significantly higher for malignant thyroid
micronodules than for benign ones. Furthermore, the
AUC of SI evaluation was greater than that of ES evaluation
(0.970 vs. 0.888, respectively); therefore, we concluded that
SI better reflects malignancy compared with ES in thyroid
micronodules.

Table 2. Sensitivity and specificity of elastosonography scoring.
Score

Benign

Malignant

1–3

106

13

4–5

2

50

Total

108

63

SN (%)

SP (%)

PPV (%)

NPV (%)

79.4

98.1

96.1

89.1

SN: Sensitivity. SP: specificity. PPV: positive predictive value. NPV: negative predictive value.
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Table 3. Area under the curve of elastosonography scoring and
strain index.

Figure. Receiver operating characteristic (ROC) curve of strain
index for distinguishing malignant micronodules from benign
ones (AUC = 0.970; 95% CI: 0.948–0.992).

Wang et al. reported 90.6% sensitivity and 89.4%
specificity for ES of 4–5 in determining malignancy
for nodules of <1 cm diameter (14). Hong et al. in their
malignancy study evaluated thyroid nodules sized <1
cm and reported 90% sensitivity, 82% specificity, 79%
PPV, and 91% NPV for ES of ≥4 (25). In our study, ES ≥4
represented malignancy, with sensitivity, specificity, PPV,
and NPV of 79.4%, 98.1%, 96.1%, and 89.1%, respectively.

Area under
curve (%)

P-value

95% confidence interval
for area under curve

ES

0.888

<0.001

0.826–0.950

SI

0.970

<0.001

0.948–0.992

The results of the present study suggested that both
ES and SI evaluations are valuable methods. Although
Unluturk et al. reported that elastography is not a
helpful method for predicting malignancy (26), our
study confirmed the usefulness of ES and SI in detecting
malignant thyroid micronodules with high sensitivity and
specificity. The optimal cutoff point for SI in diagnosing
malignancy was 3.06 in our study. The limitation of our
study was the lack of histopathological diagnosis of all
nodules. Furthermore, we did not repeat FNAB in patients
with AUS and ND cytology because that they did not
return for follow-up.
In conclusion, the incidence of thyroid micronodules
has been increasing in the general population, and the
prevalence of malignancy is higher in such nodules.
Previous studies have only recommended FNA of these
nodules when US features are suspicious for malignancy;
however, the results lack sensitivity and specificity. ES
and SI are more useful measurements for diagnosing
malignancy in thyroid micronodules.
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